Macroflux Announces Name Change to Zosano Pharma, Inc. FREMONT, Calif.--(BUSINESS WIRE)--Sept. 27, 2007--The Macroflux Corporation announced today that it has changed the name of the company to Zosano Pharma, Inc. "Our name change reflects the positive evolutionary steps the company is taking to
Macroflux Names M. Cory Zwerling President, CEO Macroflux, an emerging specialty pharmaceutical company focused on the development of proprietary products, has named M. Cory Zwerling President and CEO of the company. “This is an exciting opportunity to lead Macroflux with a strong team,
Launch of Macroflux Corporation
Macroflux Corporation has raised $75 million in an equity financing to create a new transdermal drug development company.
